The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Atossa Therapeutics Inc (NASDAQ: ATOS) was $0.92 for the day, up 0.41% from the previous closing price of $0.92. In other words, the price has increased by $0.41 from its previous closing price. On the day, 0.81 million shares were traded. ATOS stock price reached its highest trading level at $0.926 during the session, while it also had its lowest trading level at $0.89.
Ratios:
Our analysis of ATOS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.17 and its Current Ratio is at 9.17. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Maxim Group on January 26, 2018, initiated with a Buy rating and assigned the stock a target price of $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 21 ’25 when QUAY STEVEN C bought 11,239 shares for $0.88 per share. The transaction valued at 9,887 led to the insider holds 13,898 shares of the business.
Remmel H. Lawrence bought 10,000 shares of ATOS for $7,000 on Mar 26 ’25. The Director now owns 10,257 shares after completing the transaction at $0.70 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATOS now has a Market Capitalization of 118837712 and an Enterprise Value of 60489860.
Stock Price History:
The Beta on a monthly basis for ATOS is 0.99, which has changed by -0.37414968 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, ATOS has reached a high of $1.66, while it has fallen to a 52-week low of $0.55. The 50-Day Moving Average of the stock is 13.44%, while the 200-Day Moving Average is calculated to be 11.75%.
Shares Statistics:
ATOS traded an average of 824.64K shares per day over the past three months and 664830 shares per day over the past ten days. A total of 129.17M shares are outstanding, with a floating share count of 129.12M. Insiders hold about 0.04% of the company’s shares, while institutions hold 20.93% stake in the company. Shares short for ATOS as of 1757894400 were 2799971 with a Short Ratio of 3.40, compared to 1755216000 on 3659803. Therefore, it implies a Short% of Shares Outstanding of 2799971 and a Short% of Float of 2.17.
Earnings Estimates
The market rating for Atossa Therapeutics Inc (ATOS) is a result of the insights provided by 3.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.23 and -$0.26 for the fiscal current year, implying an average EPS of -$0.25. EPS for the following year is -$0.28, with 3.0 analysts recommending between -$0.26 and -$0.31.
